NasdaqCM - Nasdaq Real Time Price USD

Nuwellis, Inc. (NUWE)

0.2333 -0.0149 (-6.00%)
As of 3:43 PM EDT. Market Open.
Loading Chart for NUWE
DELL
  • Previous Close 0.2482
  • Open 0.2381
  • Bid 0.2294 x 1400
  • Ask 0.2350 x 3000
  • Day's Range 0.2257 - 0.2484
  • 52 Week Range 0.1300 - 3.8300
  • Volume 2,208,449
  • Avg. Volume 5,628,606
  • Market Cap (intraday) 3.551M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -6.3600
  • Earnings Date Aug 6, 2024 - Aug 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 9.00

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

www.nuwellis.com

59

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NUWE

Performance Overview: NUWE

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NUWE
59.78%
S&P 500
10.01%

1-Year Return

NUWE
91.58%
S&P 500
27.23%

3-Year Return

NUWE
99.93%
S&P 500
27.59%

5-Year Return

NUWE
100.00%
S&P 500
86.61%

Compare To: NUWE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NUWE

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    3.78M

  • Enterprise Value

    3.09M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.09

  • Price/Book (mrq)

    4.27

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -202.97%

  • Return on Assets (ttm)

    -82.18%

  • Return on Equity (ttm)

    -248.15%

  • Revenue (ttm)

    8.89M

  • Net Income Avi to Common (ttm)

    -21.01M

  • Diluted EPS (ttm)

    -6.3600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.4M

  • Total Debt/Equity (mrq)

    79.93%

  • Levered Free Cash Flow (ttm)

    -10.72M

Research Analysis: NUWE

Company Insights: NUWE

Research Reports: NUWE

People Also Watch